Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2015 | 09-2014 | 09-2013 | 09-2012 | 09-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 534,862 | 570,614 | 457,572 | 492,600 | 551,512 |
| Marketable Securities | 138,901 | 231,208 | 140,267 | 302,693 | 391,281 |
| Receivables | 101,563 | 86,168 | 97,460 | 43,495 | 61,815 |
| Inventories | 13,872 | 8,536 | 10,093 | 16,700 | 26,244 |
| Income taxes - deferred | N/A | 86,445 | 84,238 | 80,966 | 90,869 |
| TOTAL | $821,229 | $1,005,851 | $818,579 | $970,286 | $1,158,598 |
| Non-Current Assets | |||||
| PPE Net | 403,091 | 289,755 | 242,917 | 254,676 | 117,107 |
| Investments And Advances | 321,015 | 296,335 | 306,338 | 361,614 | 272,797 |
| Intangibles | 435,215 | 341,274 | 321,039 | 337,901 | 314,833 |
| Other Non-Current Assets | 152,743 | 50,797 | 49,072 | 36,321 | 21,052 |
| TOTAL | $1,312,064 | $978,161 | $919,366 | $990,512 | $725,789 |
| Total Assets | $2,133,293 | $1,984,012 | $1,737,945 | $1,960,798 | $1,884,387 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 20,710 | 15,898 | 10,695 | 14,831 | 10,887 |
| Accrued Expenses | 169,307 | 158,376 | 137,795 | 116,092 | 117,035 |
| TOTAL | $209,681 | $189,370 | $172,815 | $156,840 | $159,385 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 18,910 | 12,496 | 20,931 | 23,493 | 26,701 |
| Other Non-Current Liabilities | 75,174 | 41,098 | 44,410 | 39,005 | 22,140 |
| TOTAL | $107,605 | $62,994 | $65,104 | $60,725 | $39,652 |
| Total Liabilities | $317,286 | $252,364 | $237,919 | $217,565 | $199,037 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 100,851 | 102,287 | 101,763 | 102,436 | 108,736 |
| Common Shares | 102 | 103 | 102 | 103 | 110 |
| Retained earnings | 1,800,857 | 1,660,485 | 1,454,382 | 1,709,479 | 1,445,189 |
| Other shareholders' equity | -2,523 | 24,645 | 26,730 | 33,651 | 29,370 |
| TOTAL | $1,816,007 | $1,731,648 | $1,500,026 | $1,743,233 | $1,685,350 |
| Total Liabilities And Equity | $2,133,293 | $1,984,012 | $1,737,945 | $1,960,798 | $1,884,387 |